La enfermedad renal crónica, una epidemia silenciosa

  1. Patricia de Sequera 1
  1. 1 Hospital Infanta Leonor
    info

    Hospital Infanta Leonor

    Madrid, España

    ROR https://ror.org/05nfzf209

Revista:
RIECS: Revista de Investigación y Educación en Ciencias de la Salud

ISSN: 2530-2787

Año de publicación: 2023

Volumen: 8

Número: 2

Páginas: 3-10

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_opene_Buah editor

Otras publicaciones en: RIECS: Revista de Investigación y Educación en Ciencias de la Salud

Resumen

Chronic Kidney Disease (CKD) represents one of the main public health problems due to its high prevalence, the severity of its complications and high associated cardiovascular morbidity and mortality, and finally the impact on health systems, with high economic and social costs. In Spain, according to epidemiological studies, it affects approximately 10% -15% of the adult population. It is commonly called the “silent” disease, because despite this high prevalence (it is estimated that 1 in 7 Spanish adults suffer from this disease) there is an underdiagnosis, because CKD does not produce symptoms until it is in very advanced stages. Among the causes that can lead to CKD, diabetes is in the first place, a disease whose incidence continues to increase, mainly related to obesity and which represents the cause of 25% of patients who begin renal replacement treatment. The second cause is unrelated or unknown, which constitutes 18%. The diagnosis is simple, with a blood test that includes the determination of creatinine, which allows us to measure the glomerular filtration rate (kidney function), and also the determination of albumin in urine. CKD is classified into 5 stages or grades, in stage 1 the kidney function is normal, but there are alterations inthe composition of the urine or structure of the kidney and in stage 5 the patient has a renal filtration rate or function of less than 15 ml/min. The most important complication of CKD is that it increases cardiovascular risk.

Referencias bibliográficas

  • Otero A, de FA, Gayoso P, Garcia F: Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia 2010, 30(1):78-86.
  • Gorostidi M, Sánchez-Martínez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamaría R, del Pino MD, Guallar-Castillón P, de Álvaro F, Rodríguez-Artalejo F, Banegas JR. Prevalencia de enfermedad renal crónica en España: impacto de la acumulación de factores de riesgo cardiovascular. Nefrologia 2018;38:606-615.
  • Llisterri JL, Micó-Pérez RM, Velilla-Zancada S, Rodríguez-Roca GC, Prieto-Díaz MÁ, Martín-Sánchez V, et al. Prevalence of chronic kidney disease and associated factors in the Spanish population attended in primary care: Results of the IBERICAN study. Med Clin (Barc). 2021;156:157–65.
  • Registro Español de Enfermos Renales (REER) 2021. Disponible en https://www.senefro.org/contents/webstructure/MEMORIA_REER_2021_PRELIMINAR.pdf
  • Ortiz A, Sanchez-Niño MD, Crespo-Barrio M, De-Sequera-Ortiz P, Fernández-Giráldez E, García-Maset R, Macía-Heras M, Pérez-Fontán M, Rodríguez-Portillo M, Salgueira-Lazo M, Sánchez-Álvarez E, Santamaría-Olmo R, Simal-Blanco F, Pino-Pino MD. The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem. Nefrologia (Engl Ed). 2019;39:29-34.
  • KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3 2013:1-150.
  • Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, CastroS, et al. OPTN/SRTR 2017 Annual Data Report: Kidney. Am JTransplant. 2019;19 Suppl2:19–23
  • Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, et al.Long-term consequences of kidney donation. N Engl J Med.2009;360:459–69.
  • Global data on donation and transplantation (GODT)[Internet]. [consultado agosto 2023]. Disponible en: https://www.transplant-observatory.org/wp-content/uploads/2023/04/NL_GODT-PRELIMINARY-REPORT-2022.pdf
Fuente de los datos: Dialnet